"Revolutionary Vaccine Defeats Hospital Superbugs, Including MRSA"

Researchers at the University of Southern California (USC) have developed an experimental vaccine that activates immune cells to protect against drug-resistant superbugs. The vaccine, administered as a single dose, showed rapid protection against nine different bacteria and fungi species in mouse models. It works by boosting the body's preexisting immune cells called macrophages, which quickly neutralize incoming pathogens. The vaccine, consisting of three ingredients, including a component from a fungus found on human skin, works within 24 hours and lasts up to 28 days. The USC Stevens Center for Innovation has patented the vaccine, and a startup called ExBaq LLC is working on its development.